New Zealand markets open in 5 hours 31 minutes

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
99.64-1.90 (-1.87%)
As of 11:28AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close101.54
Bid99.39 x 1200
Ask99.41 x 900
Day's range99.20 - 100.28
52-week range74.24 - 105.61
Avg. volume1,320,576
Market cap207.575B
Beta (5Y monthly)0.46
PE ratio (TTM)27.68
EPS (TTM)3.60
Earnings dateN/A
Forward dividend & yield3.50 (3.43%)
Ex-dividend date09 Mar 2023
1y target est117.25
  • Yahoo Finance Video

    The 10 pharma companies participating in Medicare price negotiations

    Ten pharmaceutical manufacturers are signing the Inflation Reduction Act's Medicare drug price negotiation program. These companies are Bristol Myers Squibb (BMY), AstraZeneca (AZN), Boehringer Ingelheim, Immunex, Janssen Pharmaceuticals, Pharmacyclics, Merck & Company (MRK), Janssen Biotech, Novartis (NVS), and Novo Nordisk (NVO), according to the Biden administration. Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

  • Bloomberg

    Novartis Weighs Selling Assets from Radiopharma Unit

    (Bloomberg) -- Novartis AG is considering selling part of radiopharmaceuticals company Advanced Accelerator Applications, people with knowledge of the matter said, as it joins an industry-wide push to cast off low-growth business lines.Most Read from BloombergWhy a US Recession Is Still Likely — and Coming SoonKey Taiwan Tech Firms Helping Huawei With China Chip PlantsAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.JPMorgan’s Dimon Predicts 3.5-Day Work Week for Next Generation

  • Zacks

    Here's Why Novartis (NVS) is a Strong Value Stock

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.